- Biotech startup RWDC closes $13M round
- TPlus signs MoU with Yonsei University for dose management
- JHL Biotech receives China approval for cancer Biosimilar
- Curetis, Beijing Clear Biotech expand strategic collaboration
- Novo Nordisk launches a new obesity treatment on World Obesity Day
- Innovus Pharma receives approval from Amazon for expansion in Japan
- Prevent oral infections with bacteria-killing dentures
- GHIT Fund partners with Ono Pharmaceutical
- India & Korea ink MoU to promote Medical Devices Sector
- CPhI recognizes Merck for innovative products
- Optina Diagnostics secures C$4 M funding
- Scientists develop in vivo skin imaging technology
- MEI Pharma, BeiGene to co-develop cancer drug
- International help to treat HIV shrinks in Indonesia
-
Pharma | 05 January 2018 | News
AstraZeneca collaborates with Myriad Genetics for cancer therapy
AstraZeneca is working in collaboration with the molecular diagnostics firm Myriad Genetics’ for its tes...Read more
Digital Health | 05 January 2018 | News
Microsoft partners with Adaptive Biotechnologies
The tech giant Microsoft is partnering with Seattle biotech company Adaptive Biotechnologies on a year-long pr...Read more
-
Japan | 15 October 2018 | News
Innovus Pharma receives approval from Amazon for expansion in Japan
Innovus Pharmaceuticals, an emerging commercial-stage pharmaceutical company that delivers safe, innovative an...Read more
-
Singapore | 16 October 2018 | News
Biotech startup RWDC closes $13M round
Singapore headquartered biotech startup RWDC Industries Pte Ltd has successfully closed a $13 million Series A...Read more
-
Korea | 15 October 2018 | News
India & Korea ink MoU to promote Medical Devices Sector
In a bid to further provide an impetus and boost Indian & Korean Medical Device Industry, The Associa...Read more
-
Pharma | 04 January 2018 | News
Europe's biggest private biotech company raises $270 million
Europe’s largest privately held biotech company, Germany-based BioNTech, has raised $270 million to supp...Read more
Asia’s CRO market on the rise
A Frost & Sullivan’s recent report forecasts a growth rate of 19.9 per cent for the contract research organizations (CROs) industry in Asia Pacific (APAC) region in the period between 2015 and 2020, while the CRO market in North America is expected to grow only at 10.4 per cent CAGR. With a fast-growing pharma market, large treatment-naïve population, highly skilled and internationally acclaimed investigators, high-quality data, and harmonized regulations, APAC has become a preferred outsourcing destination for clinical trials.
